跳至主要内容
临床试验/IRCT201706191497N7
IRCT201706191497N7已完成未知

Randomized, placebo controlled, double blind clinical trial of the effect of bupropion on cancer-related fatigue

Vice Chancellor for Research,Isfahan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Inclusion criteria were at least 18 years old, having a diagnosis of cancer with survival expectancy greater than 6 months, having a cancer-related fatigue defined by a score 4 or more on a brief fatigue inventory (BFI) screening scale that ranged from 0 (none) to 10 (as bad as it can be), and hemoglobin more than 9 g/dl taken less than 4 weeks before enrollment.
  • The exclusion criteria were Karnofsky Performance Scale of <50, history of convulsive seizure, current use (within 6 weeks preceding participation) of erythropoietin, psycho stimulants or antidepressants, brain metastasis, history of fatigue prior to cancer diagnosis, any medical cause for fatigue identified on screening tests or a review of systems, hypersensitivity to bupropion and illiteracy.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research,Isfahan University of Medical Sciences

相似试验